AstraZeneca
Does this Upgrade present an opportunity for you?
Is it irrelevant, or will the Upgrade make the AstraZeneca share price more attractive?
- Itrinsic Health upgrades to Buy, with a target of 7000p.
- Consensus summary: 20 Buys, 8 Holds, 5 Sell; Average target: 6602p (Source: Bloomberg).
- Current share price 5870p (at time of writing).
- Shares -10.2% from 2019 highs; +10.5% trading from 2019 lows; -0.1% year-to date
- Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Trading AstraZeneca – An Example
Let’s say you think that AstraZeneca shares have upside potential as result of this broker upgrade. You decide to buy exposure to £10,000 worth of AstraZeneca using a CFD, at the current price of 5870p. To do this, you need £2,000.
For the purpose of this example, let’s assume the AstraZeneca share price rises to 6602p (+12.4%). Your profit would be £1240 from your initial investment of £2,000.
Conversely, let’s assume you open the above position, and place a stop-loss at 4% from the current price. AstraZeneca shares fall 4% and hit your stop-loss. Your loss would be £400.
This is provided for information purposes only. It should not be taken as a recommendation.